28/01/2025
January is Cervical Cancer Awareness Month: Join Us in the Fight Against Cervical Cancer
The Journal of Obstetrics and Gynecology of Eastern and Central Africa (JOGECA) is committed to advancing knowledge and awareness around cervical cancer. This January, we highlight key research from our journal that sheds light on various aspects of cervical cancer, its risk factors, and innovative treatment approaches.
Featured Articles:
Anticancer and Anti-Metastatic Effects of Metformin in Cervical Cancer: A Narrative Review
This article explores the potential of metformin, a common diabetes drug, in combating cervical cancer and inhibiting metastasis.
Risk Factors for Invasive Cervical Cancer Among Women Living with HIV/AIDS at Jaramogi Oginga Odinga Teaching & Referral Hospital in Kisumu County: A 5-Year Hospital-Based Case-Control Study
A comprehensive study identifying risk factors unique to women living with HIV/AIDS, providing valuable insights into prevention and management.
Tuberculosis of the Cervix Remains a Valid Differential for Cancer of the Cervix: A Case Report
This case report underscores the importance of considering tuberculosis as a differential diagnosis for cervical cancer, emphasizing accurate diagnosis and treatment.
Use of Oral Contraceptives, Depot Medroxyprogesterone Acetate, and Intrauterine Contraceptive Devices and the Risk of Cancer: A Review
A review of the relationship between contraceptive use and cancer risk, providing clarity on this critical topic for womenโs health.
Why It Matters
Cervical cancer remains a significant health challenge not only in Eastern and Central Africa but globally, with many lives affected each year. Early detection, awareness, and research are key to reducing its impact.
We invite healthcare professionals, policymakers, and the public to read and share these articles to amplify awareness and advance conversations on cervical cancer prevention, diagnosis, and treatment.
๐ Access these articles and more at: www.jogeca.com
Together, letโs work towards a future free from cervical cancer.